3Chen GX, Zhang R, Zhou HW. Heterogeneity of metallo-beta-lactamases in clinical isolates of Chryseobacterium menimgosepticum from Hangzhou, China [J]. J Antimicrob Chemother, 2006,57(4) : 750-752.
4Chiu CH,Waddigdon M,Hsieh WS.Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised[J].Taiwan Emerg Infect Dis,2000,6(5):112.
5Nulens E,Bussels B,Bols A,etal.Recurrent bacteraemia by Chryseobacterium meningosepticum in an oncology patient with a totally implanted intravascular device[J].Clin Microb Infect,2001,7(7):391-393.
6Rossolini GM,Franceschini N,Lauretti L,et al.Cloning of a Chryseobactrium (Flavobacterium) meningosepticum chromosomal gene blaA (CME) encoding an extended-spectrum class A beta-lactamases related to the Bacteroides cephalospoinases and the VEB.I and PER beta-lactamases[J].Antimicrob Agents Chemother,1999,43(9):2193-2199.
7Bellais S,Poirel L,Naas T,et al.Genetic-biochemical analysis and distribution of the Ambler class A beta-lactamase CME-2,responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum[J].Antimicrob Agents Chemother,2000,44(1):1-9.
8Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum:an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine(Baltimore), 1997, 76( 1 ) : 30-41.
9Lim LC, Low JA, Chart KM. Chryseobacterium meningoseptiaun( Flavocterium meniogosepticum)-a report of five cases in a local hospital. Ann Academed Singapore, 1999, 28(6): 857-860.
10Rossolini GM, Franceschini N, Riccio ML, et al. Characterization and sequence of the Chryseobacterium ( Flavobacterium ) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile. Biochem J, 1998, 332(Pt 1) : 145-152.
3Chen GX,Zhang R,Zhou HW.Heterogeneity of metallo-be-ta-lactamases in clinical isolates of Chryseobacterium menim-gosepticum from Hangzhou,China[J].J Antimicrob Che-mother,2006,57(4):750-752.
